ENDRA Life Sciences Inc. financial data

Symbol
NDRA on Nasdaq
Location
3600 Green Court, Suite 350, Ann Arbor, MI
State of incorporation
DE
Fiscal year end
December 31
Former names
Endra Inc. (to 9/21/2016)
Latest financial report
10-Q/A - Q3 2024 - Nov 21, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 373 % +13.7%
Quick Ratio 251 % +78.4%
Debt-to-equity 22.8 % -39.4%
Return On Equity -141 % +29.2%
Return On Assets -115 % +20.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 537K shares
Common Stock, Shares, Outstanding 535K shares -93.6%
Entity Public Float 10.3M USD
Common Stock, Value, Issued 53 USD -93.7%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 3.13M USD -48.6%
Selling and Marketing Expense 633K USD -36.7%
General and Administrative Expense 4.21M USD -20.3%
Operating Income (Loss) -7.98M USD +35.5%
Nonoperating Income (Expense) -845K USD -3094%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -8.82M USD +25.8%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -8.82M USD +25.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.82M USD
Inventory, Net 2.71M USD -1.66%
Assets, Current 4.96M USD -22.4%
Property, Plant and Equipment, Net 80.3K USD -50.1%
Operating Lease, Right-of-Use Asset 230K USD -41.6%
Assets 8.38M USD +10.2%
Accounts Payable, Current 279K USD -33.3%
Employee-related Liabilities, Current 133K USD -51.2%
Liabilities, Current 814K USD -62.5%
Operating Lease, Liability, Noncurrent 49.8K USD -79%
Liabilities 1.77M USD -26.3%
Retained Earnings (Accumulated Deficit) -99.3M USD -9.75%
Stockholders' Equity Attributable to Parent 6.6M USD +27.1%
Liabilities and Equity 8.38M USD +10.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.14M USD +14.5%
Net Cash Provided by (Used in) Financing Activities 469K USD
Net Cash Provided by (Used in) Investing Activities -23.8K USD +11.9%
Common Stock, Shares Authorized 20M shares -75%
Common Stock, Shares, Issued 535K shares -93.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.53M USD -8.55%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.75M USD +42.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 8.8K USD
Deferred Tax Assets, Valuation Allowance 21.2M USD +14.2%
Operating Lease, Liability 237K USD -41.6%
Depreciation 11.5K USD -64.1%
Payments to Acquire Property, Plant, and Equipment 27K USD 0%
Lessee, Operating Lease, Liability, to be Paid 253K USD -44.3%
Property, Plant and Equipment, Gross 580K USD -12%
Operating Lease, Liability, Current 187K USD +11.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 203K USD +3%
Lessee, Operating Lease, Liability, to be Paid, Year One 50.7K USD +3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 16.1K USD -66.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 203K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 1.04M USD +54.7%
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 106M USD +10.7%
Depreciation, Depletion and Amortization 34.5K USD +81.3%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Operating Leases, Future Minimum Payments Due 406K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%